Cargando…

Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens

This study aimed to evaluate the density of the dendritic cells (DCs) and macrophages in oral leukoplakia (OL) and proliferative verrucous leukoplakia (PVL) by immunohistochemical analysis. We analysed paraffined tissue samples of PVL (n = 27), OL (n = 20), and inflammatory fibrous hyperplasia (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Palaçon, Mariana Paravani, de Oliveira Barbeiro, Camila, Fernandes, Darcy, Biancardi, Mariel Ruivo, Silveira, Heitor Albergoni, Ferrisse, Túlio Morandin, León, Jorge Esquiche, Kujan, Omar, Bufalino, Andreia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049257/
https://www.ncbi.nlm.nih.gov/pubmed/36982316
http://dx.doi.org/10.3390/ijms24065242
_version_ 1785014412834242560
author Palaçon, Mariana Paravani
de Oliveira Barbeiro, Camila
Fernandes, Darcy
Biancardi, Mariel Ruivo
Silveira, Heitor Albergoni
Ferrisse, Túlio Morandin
León, Jorge Esquiche
Kujan, Omar
Bufalino, Andreia
author_facet Palaçon, Mariana Paravani
de Oliveira Barbeiro, Camila
Fernandes, Darcy
Biancardi, Mariel Ruivo
Silveira, Heitor Albergoni
Ferrisse, Túlio Morandin
León, Jorge Esquiche
Kujan, Omar
Bufalino, Andreia
author_sort Palaçon, Mariana Paravani
collection PubMed
description This study aimed to evaluate the density of the dendritic cells (DCs) and macrophages in oral leukoplakia (OL) and proliferative verrucous leukoplakia (PVL) by immunohistochemical analysis. We analysed paraffined tissue samples of PVL (n = 27), OL (n = 20), and inflammatory fibrous hyperplasia (n = 20) as the control group using the immunomarkers for DCs (CD1a, CD207, CD83, CD208 and CD123) and macrophages (CD68, CD163, FXIIIa and CD209). A quantitative analysis of positive cells in the epithelial and subepithelial areas was determined. Our results showed a reduction in CD208+ cells in the subepithelial area of the OL and PVL compared to the control. Additionally, we found a higher density of FXIIIa+ and CD163+ cells in the subepithelial area in PVL compared to the OL and control. Four-way MANOVA revealed a relationship between increased CD123+ cell density in the subepithelial area of “high-risk” samples regardless of disease. Macrophages provide the first line of defence against PVL antigens, suggesting a distinct pattern of innate immune system activation in PVL compared to OL, which may contribute to the complexity and the high rate of malignant transformation in the PVL.
format Online
Article
Text
id pubmed-10049257
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100492572023-03-29 Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens Palaçon, Mariana Paravani de Oliveira Barbeiro, Camila Fernandes, Darcy Biancardi, Mariel Ruivo Silveira, Heitor Albergoni Ferrisse, Túlio Morandin León, Jorge Esquiche Kujan, Omar Bufalino, Andreia Int J Mol Sci Article This study aimed to evaluate the density of the dendritic cells (DCs) and macrophages in oral leukoplakia (OL) and proliferative verrucous leukoplakia (PVL) by immunohistochemical analysis. We analysed paraffined tissue samples of PVL (n = 27), OL (n = 20), and inflammatory fibrous hyperplasia (n = 20) as the control group using the immunomarkers for DCs (CD1a, CD207, CD83, CD208 and CD123) and macrophages (CD68, CD163, FXIIIa and CD209). A quantitative analysis of positive cells in the epithelial and subepithelial areas was determined. Our results showed a reduction in CD208+ cells in the subepithelial area of the OL and PVL compared to the control. Additionally, we found a higher density of FXIIIa+ and CD163+ cells in the subepithelial area in PVL compared to the OL and control. Four-way MANOVA revealed a relationship between increased CD123+ cell density in the subepithelial area of “high-risk” samples regardless of disease. Macrophages provide the first line of defence against PVL antigens, suggesting a distinct pattern of innate immune system activation in PVL compared to OL, which may contribute to the complexity and the high rate of malignant transformation in the PVL. MDPI 2023-03-09 /pmc/articles/PMC10049257/ /pubmed/36982316 http://dx.doi.org/10.3390/ijms24065242 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Palaçon, Mariana Paravani
de Oliveira Barbeiro, Camila
Fernandes, Darcy
Biancardi, Mariel Ruivo
Silveira, Heitor Albergoni
Ferrisse, Túlio Morandin
León, Jorge Esquiche
Kujan, Omar
Bufalino, Andreia
Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
title Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
title_full Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
title_fullStr Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
title_full_unstemmed Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
title_short Macrophages CD163+ and Factor XIIIa+ Provide a First-Line Defence against Proliferative Verrucous Leukoplakia Antigens
title_sort macrophages cd163+ and factor xiiia+ provide a first-line defence against proliferative verrucous leukoplakia antigens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049257/
https://www.ncbi.nlm.nih.gov/pubmed/36982316
http://dx.doi.org/10.3390/ijms24065242
work_keys_str_mv AT palaconmarianaparavani macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens
AT deoliveirabarbeirocamila macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens
AT fernandesdarcy macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens
AT biancardimarielruivo macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens
AT silveiraheitoralbergoni macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens
AT ferrissetuliomorandin macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens
AT leonjorgeesquiche macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens
AT kujanomar macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens
AT bufalinoandreia macrophagescd163andfactorxiiiaprovideafirstlinedefenceagainstproliferativeverrucousleukoplakiaantigens